EFFECT OF CORTICOSTEROID THERAPY ON FIBRINOLYSIS IN PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY CONDITIONS.
D000224:Addison Disease; D000236:Adenoma; D000238:Adenoma, Chromophobe; D000324:Adrenocorticotropic Hormone; D000740:Anemia; D000741:Anemia, Aplastic; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D001780:Blood Coagulation Tests; D003092:Colitis; D003093:Colitis, Ulcerative; D003348:Cortisone; D005342:Fibrinolysis; D005853:Geriatrics; D006327:Heart Block; D006801:Humans; D008180:Lupus Erythematosus, Systemic; D010600:Pharmacology; D011241:Prednisone; D011693:Purpura
D000324:Adrenocorticotropic Hormone; D003348:Cortisone; D011241:Prednisone
ADDISON'S DISEASE; ADENOMA, CHROMOPHOBE; ANEMIA, APLASTIC; ARTHRITIS, RHEUMATOID; BLOOD COAGULATION TESTS; COLITIS, ULCERATIVE; CORTICOTROPIN; CORTISONE; FIBRINOLYSIS; GERIATRICS; HEART BLOCK; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHARMACOLOGY; PREDNISONE; PURPURA